A large collection of conserved eukaryotic peptidyl-prolyl cis-trans isomerases. Some members of this group are secreted (into the ER).. Localization: Cytoplasmic (by homology) / ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0005930 | axoneme | 2 | 1 |
Related structures:
AlphaFold database: E9AQT1
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 16 |
GO:0006807 | nitrogen compound metabolic process | 2 | 16 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0018193 | peptidyl-amino acid modification | 5 | 16 |
GO:0018208 | peptidyl-proline modification | 6 | 16 |
GO:0019538 | protein metabolic process | 3 | 16 |
GO:0036211 | protein modification process | 4 | 16 |
GO:0043170 | macromolecule metabolic process | 3 | 16 |
GO:0043412 | macromolecule modification | 4 | 16 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 16 |
GO:0006457 | protein folding | 2 | 6 |
GO:0009987 | cellular process | 1 | 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 16 |
GO:0003824 | catalytic activity | 1 | 16 |
GO:0016853 | isomerase activity | 2 | 16 |
GO:0016859 | cis-trans isomerase activity | 3 | 16 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 16 |
GO:0005488 | binding | 1 | 2 |
GO:0016018 | cyclosporin A binding | 4 | 2 |
GO:0033218 | amide binding | 2 | 2 |
GO:0042277 | peptide binding | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.269 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.760 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.310 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.270 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.760 |
CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.348 |
CLV_PCSK_SKI1_1 | 281 | 285 | PF00082 | 0.595 |
CLV_PCSK_SKI1_1 | 355 | 359 | PF00082 | 0.677 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.596 |
DOC_CDC14_PxL_1 | 46 | 54 | PF14671 | 0.452 |
DOC_MAPK_gen_1 | 165 | 174 | PF00069 | 0.269 |
DOC_MAPK_gen_1 | 30 | 40 | PF00069 | 0.451 |
DOC_MAPK_MEF2A_6 | 33 | 42 | PF00069 | 0.333 |
DOC_PP1_RVXF_1 | 31 | 38 | PF00149 | 0.224 |
DOC_PP2B_LxvP_1 | 221 | 224 | PF13499 | 0.401 |
DOC_USP7_MATH_1 | 257 | 261 | PF00917 | 0.593 |
DOC_USP7_MATH_1 | 334 | 338 | PF00917 | 0.768 |
DOC_USP7_UBL2_3 | 336 | 340 | PF12436 | 0.700 |
DOC_USP7_UBL2_3 | 351 | 355 | PF12436 | 0.686 |
DOC_WW_Pin1_4 | 11 | 16 | PF00397 | 0.573 |
DOC_WW_Pin1_4 | 115 | 120 | PF00397 | 0.302 |
DOC_WW_Pin1_4 | 252 | 257 | PF00397 | 0.612 |
DOC_WW_Pin1_4 | 272 | 277 | PF00397 | 0.740 |
DOC_WW_Pin1_4 | 313 | 318 | PF00397 | 0.602 |
DOC_WW_Pin1_4 | 323 | 328 | PF00397 | 0.606 |
DOC_WW_Pin1_4 | 69 | 74 | PF00397 | 0.553 |
LIG_14-3-3_CanoR_1 | 281 | 286 | PF00244 | 0.775 |
LIG_14-3-3_CanoR_1 | 30 | 36 | PF00244 | 0.403 |
LIG_APCC_ABBA_1 | 82 | 87 | PF00400 | 0.324 |
LIG_BRCT_BRCA1_1 | 186 | 190 | PF00533 | 0.324 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.269 |
LIG_FHA_1 | 156 | 162 | PF00498 | 0.200 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.424 |
LIG_FHA_1 | 307 | 313 | PF00498 | 0.473 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.546 |
LIG_FHA_2 | 282 | 288 | PF00498 | 0.557 |
LIG_FHA_2 | 70 | 76 | PF00498 | 0.534 |
LIG_Integrin_isoDGR_2 | 202 | 204 | PF01839 | 0.288 |
LIG_LIR_Gen_1 | 124 | 133 | PF02991 | 0.311 |
LIG_LIR_Gen_1 | 216 | 225 | PF02991 | 0.367 |
LIG_LIR_Gen_1 | 233 | 239 | PF02991 | 0.172 |
LIG_LIR_Gen_1 | 34 | 43 | PF02991 | 0.290 |
LIG_LIR_Gen_1 | 76 | 85 | PF02991 | 0.308 |
LIG_LIR_Nem_3 | 124 | 129 | PF02991 | 0.311 |
LIG_LIR_Nem_3 | 216 | 221 | PF02991 | 0.346 |
LIG_LIR_Nem_3 | 233 | 238 | PF02991 | 0.172 |
LIG_LIR_Nem_3 | 34 | 40 | PF02991 | 0.290 |
LIG_LIR_Nem_3 | 44 | 49 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 76 | 82 | PF02991 | 0.387 |
LIG_MLH1_MIPbox_1 | 186 | 190 | PF16413 | 0.324 |
LIG_PDZ_Class_2 | 356 | 361 | PF00595 | 0.579 |
LIG_SH2_CRK | 114 | 118 | PF00017 | 0.260 |
LIG_SH2_CRK | 235 | 239 | PF00017 | 0.313 |
LIG_SH2_NCK_1 | 152 | 156 | PF00017 | 0.401 |
LIG_SH2_STAP1 | 235 | 239 | PF00017 | 0.313 |
LIG_SH2_STAT3 | 112 | 115 | PF00017 | 0.269 |
LIG_SH2_STAT3 | 133 | 136 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.278 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.274 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.239 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.169 |
LIG_SH2_STAT5 | 24 | 27 | PF00017 | 0.592 |
LIG_SH3_2 | 331 | 336 | PF14604 | 0.550 |
LIG_SH3_3 | 250 | 256 | PF00018 | 0.435 |
LIG_SH3_3 | 328 | 334 | PF00018 | 0.667 |
LIG_SH3_3 | 44 | 50 | PF00018 | 0.378 |
LIG_TRAF2_1 | 284 | 287 | PF00917 | 0.715 |
LIG_TRAF2_1 | 72 | 75 | PF00917 | 0.578 |
MOD_CK1_1 | 151 | 157 | PF00069 | 0.401 |
MOD_CK1_1 | 17 | 23 | PF00069 | 0.504 |
MOD_CK1_1 | 184 | 190 | PF00069 | 0.269 |
MOD_CK1_1 | 26 | 32 | PF00069 | 0.536 |
MOD_CK1_1 | 260 | 266 | PF00069 | 0.654 |
MOD_CK2_1 | 264 | 270 | PF00069 | 0.599 |
MOD_CK2_1 | 281 | 287 | PF00069 | 0.676 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.542 |
MOD_GlcNHglycan | 153 | 156 | PF01048 | 0.392 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.506 |
MOD_GlcNHglycan | 193 | 196 | PF01048 | 0.316 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.614 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.708 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.348 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.394 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.490 |
MOD_GSK3_1 | 248 | 255 | PF00069 | 0.549 |
MOD_GSK3_1 | 260 | 267 | PF00069 | 0.534 |
MOD_GSK3_1 | 268 | 275 | PF00069 | 0.666 |
MOD_GSK3_1 | 277 | 284 | PF00069 | 0.752 |
MOD_GSK3_1 | 323 | 330 | PF00069 | 0.478 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.449 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.458 |
MOD_LATS_1 | 353 | 359 | PF00433 | 0.537 |
MOD_N-GLC_1 | 184 | 189 | PF02516 | 0.324 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.322 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.648 |
MOD_NEK2_1 | 335 | 340 | PF00069 | 0.690 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.480 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.478 |
MOD_NEK2_1 | 9 | 14 | PF00069 | 0.553 |
MOD_NEK2_2 | 138 | 143 | PF00069 | 0.303 |
MOD_PIKK_1 | 184 | 190 | PF00454 | 0.324 |
MOD_PIKK_1 | 257 | 263 | PF00454 | 0.539 |
MOD_PIKK_1 | 41 | 47 | PF00454 | 0.525 |
MOD_PIKK_1 | 52 | 58 | PF00454 | 0.540 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.269 |
MOD_Plk_1 | 73 | 79 | PF00069 | 0.548 |
MOD_Plk_4 | 121 | 127 | PF00069 | 0.320 |
MOD_Plk_4 | 245 | 251 | PF00069 | 0.555 |
MOD_Plk_4 | 74 | 80 | PF00069 | 0.485 |
MOD_ProDKin_1 | 11 | 17 | PF00069 | 0.571 |
MOD_ProDKin_1 | 115 | 121 | PF00069 | 0.302 |
MOD_ProDKin_1 | 252 | 258 | PF00069 | 0.612 |
MOD_ProDKin_1 | 272 | 278 | PF00069 | 0.741 |
MOD_ProDKin_1 | 313 | 319 | PF00069 | 0.602 |
MOD_ProDKin_1 | 323 | 329 | PF00069 | 0.609 |
MOD_ProDKin_1 | 69 | 75 | PF00069 | 0.559 |
MOD_SUMO_rev_2 | 162 | 166 | PF00179 | 0.159 |
TRG_DiLeu_BaEn_3 | 74 | 80 | PF01217 | 0.502 |
TRG_ENDOCYTIC_2 | 114 | 117 | PF00928 | 0.260 |
TRG_ENDOCYTIC_2 | 235 | 238 | PF00928 | 0.372 |
TRG_ER_diArg_1 | 166 | 168 | PF00400 | 0.162 |
TRG_ER_diArg_1 | 7 | 9 | PF00400 | 0.551 |
TRG_ER_diArg_1 | 96 | 98 | PF00400 | 0.348 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJB8 | Leptomonas seymouri | 80% | 99% |
A0A1X0P0F8 | Trypanosomatidae | 60% | 100% |
A0A3Q8IDR1 | Leishmania donovani | 94% | 100% |
A0A3R7MER6 | Trypanosoma rangeli | 62% | 100% |
A0A3S7WXF4 | Leishmania donovani | 34% | 100% |
A4H8P7 | Leishmania braziliensis | 78% | 95% |
A4HCL8 | Leishmania braziliensis | 35% | 100% |
A4HX17 | Leishmania infantum | 92% | 99% |
A4I042 | Leishmania infantum | 33% | 100% |
C9ZVY5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 100% |
E9AW05 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
G5EEW6 | Caenorhabditis elegans | 28% | 85% |
Q13356 | Homo sapiens | 32% | 69% |
Q4QBH1 | Leishmania major | 37% | 100% |
Q4QEP7 | Leishmania major | 90% | 100% |
V5DJ29 | Trypanosoma cruzi | 60% | 100% |